Search results

Evidence-based recommendations on temozolomide (Temodal) for malignant glioma in children over 3 years, young people and adults.

Result type

Technology appraisal guidance

Last updated

3 March 2016

Evidence-based recommendations on transcranial magnetic stimulation for treating and preventing migraine. This involves placing a handheld device on the scalp to deliver magnetic pulses to the head.

Result type

Interventional procedures guidance

Published

23 January 2014

Summary of the evidence on rifaximin for treating pouchitis to inform local NHS planning and decision-making

Result type

Evidence summary

Published

25 March 2014

In development Reference number: GID-IPG10440 Expected publication date: TBC

Result type

Interventional procedures guidance

Status

In development

We are listening to your views on this Interventional procedures guidance. Comments close 7 January 2026.

Result type

Interventional procedures guidance

Status

In consultation

Summary of the evidence on midodrine for orthostatic hypotension due to autonomic dysfunction to inform local NHS planning and decision-making

Result type

Evidence summary

Published

6 October 2015

Evidence-based recommendations on erythropoiesis-stimulating agents (epoetin alfa [Eprex], epoetin beta [NeoRecormon], epoetin theta, epoeitin zeta [Retacrit] and darbepoetin alfa [Aranesp]) for treating anaemia in adults with cancer having chemotherapy.

Result type

Technology appraisal guidance

Published

26 November 2014

Evidence-based recommendations on occipital nerve stimulation for intractable chronic migraine. This involves using implanted electrodes to deliver electrical impulses to the occipital nerve to mask migraine pain.

Result type

Interventional procedures guidance

Published

26 April 2013

Evidence-based recommendations on eliglustat (Cerdelga) for treating type 1 Gaucher disease in adults.

Result type

Highly specialised technologies guidance

Published

28 June 2017

Evidence-based recommendations on atogepant (Aquipta) for preventing migraine in adults.

Result type

Technology appraisal guidance

Published

15 May 2024

Discontinued Reference number: GID-TA10425

Result type

Technology appraisal guidance

Status

Discontinued

Evidence-based recommendations on transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine in adults. This involves attaching a small device on the forehead to send small electrical currents to the nerves that bring sensation to the upper eyelids, forehead and scalp.

Result type

Interventional procedures guidance

Published

26 October 2022

Evidence-based recommendations on deep brain stimulation for intractable trigeminal autonomic cephalalgias. This involves delivering electrical impulses to a precise area of the brain using an electrode to mask the pain.

Result type

Interventional procedures guidance

Published

23 March 2011

Evidence-based recommendations on burosumab (Crysvita) for X-linked hypophosphataemia in children and young people.

Result type

Highly specialised technologies guidance

Last updated

8 April 2025

Evidence-based recommendations on velmanase alfa (Lamzede) for treating alpha-mannosidosis in people under 18 years and in people who turn 18 while on treatment.

Result type

Highly specialised technologies guidance

Published

13 December 2023